Fundación MEDINA, created in 2008, is a non-profit public-private partnership between Merck Sharp and Dohme de España S.A., the Junta de Andalucía and the University of Granada, to discover new compounds and innovative therapies for unmet medical needs.
Its foundations come from the former Merck Basic Research Center in Madrid (CIBE), including CIBE’s assets and know-how, and over 50 years of experience in drug discovery from natural products and preclinical evaluation of drug candidates. For more information visit: http://www.medinaandalucia.es
Today’s MSD is a global healthcare leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., with headquarters in Whitehouse Station, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. MSD. Be well. For more information, visit http://www.msd.com